Patents

US 12090261 B2: Method for modulating endothelial glycocalyx structure

Granted
2024-09-17
Filed
2021-11-15 application 17526663
Type
Utility · 17 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention provides methods and devices for augmenting impaired glycocalyx barrier function in a subject in need thereof by contacting a sample (e.g., blood) obtained from the subject with a glycocalyx-mimetic adsorption media. The adsorption media includes glycosaminoglycan structures and, optionally, proteoglycan core proteins, which are conducive to enhancing and/or restoring the impaired glycocalyx barrier function in a sample. The contacted sample is subsequently separated from the adsorption media, producing a treated sample that can be infused into the subject. Methods and devices for treating a patient suffering from a disease associated with glycocalyx barrier dysfunction are also provided herein.

Source: PVGPATDIS, file of 2026-04-10 (ipg240917.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
EXTHERA MEDICAL CORPORATION 22 patentsUS company or organizationMartinez, CAExThera Medical Corp Form D issuer FUZZY medium confidence: same name (legal endings aside) and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Robert S. WardMartinez, CA28PVGPATDIS, file of 2026-04-10
Keith R. McCreaMartinez, CA22PVGPATDIS, file of 2026-04-10
Lakhmir (Mink) ChawlaMartinez, CA1PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61MDevices for introducing media into, or onto, the body ; devices for transducing body media or for taking media from the body ; devices for producing or ending sleep or stuporA61M1/3679PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/726PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P3/10PVGPATDIS, file of 2026-04-10
B01JChemical or physical processes, e.g. catalysis or colloid chemistry; their relevant apparatusB01J20/24PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-04-08Assignment
Assignment of assignor's interest
WARD, ROBERT S. signed 2020-06-09
MCCREA, KEITH R. signed 2020-06-16
CHAWLA, LAKHMIR (MINK) signed 2020-06-15
EXTHERA MEDICAL CORPORATION MARTINEZ, CA59548/749PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.